19 Feb 2021 --- A new clinical study examining DolCas Biotech’s Curcugen suggests curcumin’s anti-inflammatory pathway could support both mood and digestive health through the gut-brain axis. Researchers found that DolCas Biotech’s curcuminoids formula, Curcugen, significantly reduced both self-reported gastrointestinal symptoms (reflux, abdominal pain, indigestion, diarrhea and constipation) and scores on the Depression, Anxiety, and Stress scale.
